Business
Groupe Athena, Inc. Enters Multi Year Contractual Relationship With Major Bangladesh Pharmaceutical Manufacturer
Groupe Athena, Inc. Enters Multi Year Contractual Relationship With Major Bangladesh Pharmaceutical Manufacturer.
About this update from Ayujoy Herbals Ltd.
[{"type":"text","content":"\n\n\n\n\n\n\n\nGroupe Athena, Inc. Enters Multi Year Contractual Relationship With Major Bangladesh Pharmaceutical Manufacturer\n\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:\"0in\";\n}\n\n\n\n\n\n\n\n\n\n\nGroupe Athena, Inc. Enters Multi Year Contractual Relationship With Major Bangladesh Pharmaceutical Manufacturer\n\nPR Newswire\n\nMUMBAI, India, March 4, 2013\n\n\n\n\n\n\n\nMUMBAI, India, March 4, 2013 /PRNewswire/ -- Groupe Athena, Inc. (OTCPink:GATA) announced today they have entered into a multiyear contract with Eskayef Bangladesh LTD., a leading Indian pharmaceutical manufacturer. Under the terms of the agreement Groupe Athena will assist Eskayef in obtaining FDA approval for their Bangladesh manufacturing facility during the first stage, and assist with U.S approval of individual drugs in subsequent stages of the agreement. The contract could result in a 20% increase to annual revenues beginning fiscal 2014.\n\n\nMr. M. Motiar Rehman, General Manager of Eskayef stated the following with regard to the agreement: \"We are very pleased to enter into an agreement with Groupe Athena, Inc. for getting our facilities approved by the FDA. We are excited by the prospect of entering the U.S. market and want to focus more resources in the United States once we get our facilities approved. We are hoping for a long and fruitful partnership with Groupe Athena Inc., in fulfilling this objective.\" \n\n\nGroupe Athena Chairman, D. Purohit stated, \"We are extremely proud to be able to align ourselves with such a dynamic company as Eskayef Bangladesh. Once the facilities are approved by the FDA, Eskayef is planning to become a contract manufacturer and Groupe Athena will be assisting Eskayef in getting their drugs approved and identifying suitable partners in the United States\". \n\n\nThe Indian pharmaceutical industry has grown dramatically and was estimated to be over $21 Billion in 2010 with continued double digit annual growth expected through this decade. GATA has emerged as a vital component to this growth by its ability to help Indian manufacturers get their products approv...